Tag: tumorSize

Articles

• Reasons to have regular screening mammograms starting at age 40

News

• Characteristics of breast cancer in women under 40
• Chemotherapy improves HER2+ and triple negative outcomes even for small (1cm) tumors
• DCIS incidence has increased in recent years
• Early detection with screening mammograms leads to improved breast cancer survival
• Early recurrence more likely with triple negative breast cancer, but risk of recurrence not higher
• Herceptin has reduced locoregional recurrence for HER2+ compared to triple negative breast cancer
• Inflammatory breast cancer patients continue to have poorer prognosis
• Likelihood of late recurrence for hormone receptor positive breast cancer is hard to predict
• Lobular and ductal breast cancer can be treated similarly based on other important tumor characteristics
• Locoregional recurrence indicates poor prognosis 10 or more years after lumpectomy
• Lumpectomy is not inferior to mastectomy for appropriately selected triple negative patients
• Male breast cancer survival is influenced by age, tumor size, ER status and lymph node involvement
• Multifocal breast cancer has worse prognosis than single tumors
• Number of tumors should be considered in staging multicentric/multifocal breast cancer
• Residual cancer after chemotherapy
• Small triple negative tumors have worse prognosis than small ER+/PR+ tumors
• Triple negative breast cancer prognosis is influenced even by small number of positive nodes
• Tumor marker CA 27.29 has limited usefulness in determining initial prognosis
• Tumor response to anti-estrogen treatment before surgery is influenced by BMI and race

Studies

• A Case-Match Study Comparing Unilateral With Synchronous Bilateral Breast Cancer Outcomes
• A Quantitative Multigene RT-PCR Assay for Predicting Recurrence Risk after Surgical Excision Alone without Irradiation for Ductal Carcinoma In Situ (DCIS): A Prospective Validation Study of the DCIS Score from ECOG E5194
• A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma
• Addition of Trastuzumab May Potentially Equalize Disease-Free Survival Outcomes Among Obese and Normal-Weight Patients
• Association between race and BMI with response to neoadjuvant endocrine therapy in postmenopausal women with large estrogen receptor-positive breast cancers
• Biologic markers determine both the risk and the timing of recurrence in breast cancer
• Breast cancer in women under 40 years of age: A series of 57 cases from Northern Ireland
• Breast cancer multifocality, disease extent, and survival
• Clear margins for invasive lobular carcinoma: a surgical challenge
• Clinicopathological Characteristics and Survival Analysis of 87 Male Breast Cancer Cases
• Combination of methylselenocysteine with tamoxifen inhibits MCF-7 breast cancer xenografts in nude mice through elevated apoptosis and reduced angiogenesis
• Comparing survival with breast-conservation therapy or mastectomy in the management of young women with early-stage breast cancer
• Comparison of clinicopathological characteristics and prognoses between bilateral and unilateral breast cancer
• Comparison of locoregional recurrence in triple-negative and HER2-positive breast cancer subtype after breast-conserving therapy and modern systemic therapy
• Conservative surgery in patients with multifocal/multicentric breast cancer
• Curcumin Suppresses the Paclitaxel-Induced Nuclear Factor-[kappa]B in Breast Cancer Cells and Potentiates the Growth Inhibitory Effect of Paclitaxel in a Breast Cancer Nude Mice Model
• Delays in Primary Surgical Treatment Are Not Associated with Significant Tumor Size Progression in Breast Cancer Patients
• Differences in survival among women with stage III inflammatory and noninflammatory locally advanced breast cancer appear early: A large population-based study
• Does mammography affect the nodal status at presentation in 40- to 49-year-old breast cancer patients?
• Does multicentric/multifocal breast cancer differ from unifocal breast cancer? An analysis of survival and contralateral breast cancer incidence
• Ductal Carcinoma In Situ of the Breast: A Systematic Review of Incidence, Treatment, and Outcomes
• Effect of Obesity on Prognosis after Early Breast Cancer
• Exploring the use and impact of adjuvant Trastuzumab for HER2-positive breast cancer patients in a large UK cancer network
• Impact of a Raised Body Mass Index on Breast Cancer Survival in Relation to Age and Disease Extent at Diagnosis
• Is breast-conserving therapy a safe option for patients with tumor multicentricity and multifocality?
• Lobular Breast Cancer: Same Survival and Local Control Compared with Ductal Cancer, but Should Both Be Treated the Same Way? Analysis of an Institutional Database over a 10-Year Period
• Locoregional recurrence after breast conserving therapy remains an independent prognostic factor even after an event free interval of ten years in early stage breast cancer
• Male breast cancer: An institution’s 25-year experience
• Male breast carcinoma in United States: Survival rate and determinants of prognosis
• Mammographic Breast Density and Subsequent Risk of Breast Cancer in Postmenopausal Women According to Tumor Characteristics
• Multicentric and multifocal versus unifocal breast cancer: is the tumor-node-metastasis classification justified?
• Multifocality as a prognostic factor in breast cancer patients registered in Danish Breast Cancer Cooperative Group (DBCG) 1996-2001
• Nodal Status and Clinical Outcomes in a Large Cohort of Patients With Triple-Negative Breast Cancer
• Obesity, Adjuvant Therapy, and Survival Outcomes in Early-Stage Breast Cancer
• Occult axillary lymph node metastasis do not have prognostic significance in early stage breast cancer
• Pathological and mammographic prognostic factors for screen detected cancers in a multi-centre randomised, controlled trial of mammographic screening in women from age 40 to 48 years
• Potential mechanisms whereby the lignan or oil components of flaxseed, alone or in combination with tamoxifen exert their effect on breast cancer
• Presence of an in situ component is associated with reduced biological aggressiveness of size-matched invasive breast cancer
• Prevalence of CA 27.29 in Primary Breast Cancer Patients before the Start of Systemic Treatment
• Prognosis and Outcome of Small (1 cm), Node-Negative Breast Cancer on the Basis of Hormonal and HER-2 Status
• Prognosis and pathology of screen-detected carcinomas: How different are they?
• Prognosis of medullary breast cancer: Analyses of 13 International Breast Cancer Study Group (IBCSG) trials
• Prognostic impact of isolated tumor cells in breast cancer axillary nodes: single tumor cell(s) versus tumor cell cluster(s) and microanatomic location
• Prognostic significance of triple negative breast cancer at tumor size 1 cm and smaller
• Raising gestational choline intake alters gene expression in DMBA-evoked mammary tumors and prolongs survival
• Recurrence pattern in early-stage breast cancer in a minority cohort
• Should palpable DCIS be treated as IDC? A retrospective audit
• Significance of palpability in invasive lobular carcinoma of the breast
• Small node-negative (T1b-cN0) invasive hormone receptor-positive breast cancers: Is there a subpopulation that might have benefit from adjuvant chemotherapy?
• Suppression of implanted MDA-MB 231 human breast cancer growth in nude mice by dietary walnut
• Triple negative receptor status as a risk factor for recurrence and death in cancer of the breast
• Triple-Negative Breast Cancer Is Not a Contraindication for Breast Conservation
• Tumor infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer
• Walnut consumption slows growth of MDA-MB 231 xenografts
• Walnuts May Prevent Breast Cancer